The European Medicines Agency (EMA) will allow Novo Nordisk to add risk reduction for events related to kidney disease to the ...
The European Medicines Agency (EMA) will allow Novo Nordisk to add risk reduction for events related to kidney disease to the ...
The EMA approved a kidney disease–related label expansion for the blockbuster GLP-1 drug after a study showed reduced risk of ...
What he thought was the flu turned out to be end-stage kidney disease. Now 20-year-old Liam Clegg is looking for a living ...
Kidneys may not be the first organs that come to mind when patients present with seemingly unrelated symptoms. What rare ...
New potential therapeutic targets have been identified for diabetic kidney disease (DKD) - the leading cause of kidney ...
Preventing or delaying the onset of end-stage kidney disease is vital. By implementing a results-driven, value-based approach ...